Davenport & Co’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.06M Sell
3,779
-52
-1% -$13.7K 0.01% 757
2026
Q1
$1.02M Buy
3,831
+20
+0.5% +$5.42K 0.01% 709
2025
Q4
$956K Sell
3,811
-103
-3% -$27.4K 0.01% 711
2025
Q3
$1.12M Buy
3,914
+13
+0.3% +$3.48K 0.01% 661
2025
Q2
$1.02M Buy
3,901
+181
+5% +$44.1K 0.01% 678
2025
Q1
$866K Sell
3,720
-269
-7% -$65.3K 0.01% 694
2024
Q4
$915K Buy
3,989
+229
+6% +$52.5K 0.01% 663
2024
Q3
$840K Buy
3,760
+8
+0.2% +$1.76K ﹤0.01% 675
2024
Q2
$764K Buy
3,752
+317
+9% +$64.5K ﹤0.01% 681
2024
Q1
$751K Sell
3,435
-203
-6% -$44.7K ﹤0.01% 692
2023
Q4
$827K Buy
3,638
+27
+0.7% +$5.67K 0.01% 632
2023
Q3
$726K Sell
3,611
-2,169
-38% -$457K 0.01% 622
2023
Q2
$1.03M Sell
5,780
-1,261
-18% -$245K 0.01% 549
2023
Q1
$1.39M Sell
7,041
-196
-3% -$40.3K 0.01% 456
2022
Q4
$1.46M Buy
7,237
+123
+2% +$24K 0.01% 423
2022
Q3
$1.25M Sell
7,114
-27
-0.4% -$5.53K 0.01% 442
2022
Q2
$1.44M Sell
7,141
-435
-6% -$92.7K 0.01% 423
2022
Q1
$1.72M Sell
7,576
-619
-8% -$146K 0.01% 425
2021
Q4
$2.21M Buy
8,195
+54
+0.7% +$13.4K 0.01% 388
2021
Q3
$1.97M Buy
8,141
+1
+0% +$252 0.01% 384
2021
Q2
$1.93M Buy
8,140
+302
+4% +$68.8K 0.01% 340
2021
Q1
$1.72M Buy
7,838
+1,586
+25% +$318K 0.02% 307
2020
Q4
$1.09M Sell
6,252
-116
-2% -$20K 0.01% 352
2020
Q3
$1.03M Buy
6,368
+931
+17% +$148K 0.01% 334
2020
Q2
$776K Buy
5,437
+1,211
+29% +$168K 0.01% 368
2020
Q1
$459K Sell
4,226
-181
-4% -$26.1K 0.01% 430
2019
Q4
$640K Sell
4,407
-246
-5% -$35.5K 0.01% 423
2019
Q3
$691K Sell
4,653
-17
-0.4% -$2.48K 0.01% 391
2019
Q2
$694K Hold
4,670
0.01% 389
2019
Q1
$614K Sell
4,670
-341
-7% -$42K 0.01% 381
2018
Q4
$544K Sell
5,011
-95
-2% -$12.7K 0.01% 383
2018
Q3
$762K Sell
5,106
-4,031
-44% -$613K 0.01% 359
2018
Q2
$1.41M Buy
9,137
+4,606
+102% +$695K 0.02% 280
2018
Q1
$630K Sell
4,531
-850
-16% -$125K 0.01% 398
2017
Q4
$737K Buy
5,381
+87
+2% +$11.5K 0.01% 374
2017
Q3
$687K Sell
5,294
-22
-0.4% -$2.93K 0.01% 376
2017
Q2
$704K Sell
5,316
-140
-3% -$17.1K 0.01% 360
2017
Q1
$602K Hold
5,456
0.01% 374
2016
Q4
$601K Buy
5,456
+244
+5% +$27.1K 0.01% 374
2016
Q3
$616K Sell
5,212
-1,623
-24% -$191K 0.01% 372
2016
Q2
$765K Buy
6,835
+87
+1% +$9.36K 0.01% 337
2016
Q1
$679K Buy
6,748
+58
+0.9% +$5.56K 0.01% 338
2015
Q4
$711K Sell
6,690
-52
-0.8% -$5.37K 0.01% 324
2015
Q3
$628K Hold
6,742
0.01% 338
2015
Q2
$702K Buy
6,742
+291
+5% +$30.3K 0.01% 331
2015
Q1
$699K Buy
6,451
+768
+14% +$79K 0.01% 344
2014
Q4
$527K Sell
5,683
-425
-7% -$37.5K 0.01% 365
2014
Q3
$534K Buy
6,108
+233
+4% +$21.1K 0.01% 350
2014
Q2
$517K Sell
5,875
-116
-2% -$10K 0.01% 364
2014
Q1
$505K Sell
5,991
-18
-0.3% -$1.44K 0.01% 363
2013
Q4
$472K Sell
6,009
-58
-1% -$4.95K 0.01% 370
2013
Q3
$517K Sell
6,067
-233
-4% -$19.6K 0.01% 346
2013
Q2
$542K Buy
+6,300
New +$523K 0.01% 305

Other funds holding LH

Davenport & Co's LH Position: Q2 2026 in Review

Davenport & Co reduced its Labcorp (LH) stake by 1.4% in Q2 2026, selling an estimated $13.7K and leaving 3,779 shares worth $1.06M. The position accounts for 0.01% of the portfolio, ranked #757.

Davenport & Co first reported a position in LH in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.21M in Q4 2021. 215 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Davenport & Co held 3,779 shares of Labcorp worth $1.06M as of Q2 2026.
  • Davenport & Co sold 52 Labcorp shares in Q2 2026, an estimated $13.7K.
  • Labcorp made up 0.01% of Davenport & Co's portfolio in Q2 2026, its #757 holding.
  • Davenport & Co first reported a position in Labcorp in Q2 2013 and has held it in 53 quarters since.
  • Davenport & Co's Labcorp position peaked at $2.21M in Q4 2021.
  • 215 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Davenport & Co's 13F filing for Q2 2026, filed 13 Jul 2026.